These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36637406)

  • 1. Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes.
    Gellen B; Thorin-Trescases N; Thorin E; Gand E; Ragot S; Montaigne D; Pucheu Y; Mohammedi K; Gatault P; Potier L; Liuu E; Hadjadj S; Saulnier PJ;
    ESC Heart Fail; 2022 Dec; 9(6):3909-3919. PubMed ID: 36637406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of diabetes, heart failure, and N-terminal pro-B-type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation.
    Hofer F; Pailer U; Sulzgruber P; Gerges C; Winter MP; Giugliano RP; Gottsauner-Wolf M; Hülsmann M; Kazem N; Koller L; Schönbauer R; Niessner A; Hengstenberg C; Zelniker TA
    ESC Heart Fail; 2022 Aug; 9(4):2367-2377. PubMed ID: 35593128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Greene SJ; Maggioni AP; Fonarow GC; Solomon SD; Böhm M; Kandra A; Prescott MF; Reimund B; Hua TA; Lesogor A; Zannad F; Gheorghiade M;
    Eur J Heart Fail; 2015 Jan; 17(1):98-108. PubMed ID: 25597870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.
    Iguchi M; Wada H; Shinozaki T; Suzuki M; Ajiro Y; Matsuda M; Koike A; Koizumi T; Shimizu M; Ono Y; Takenaka T; Sakagami S; Morita Y; Fujimoto K; Yonezawa K; Yoshida K; Ninomiya A; Nakamura T; Funada J; Kajikawa Y; Oishi Y; Kato T; Kotani K; Abe M; Akao M; Hasegawa K;
    ESC Heart Fail; 2021 Oct; 8(5):4187-4198. PubMed ID: 34387398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
    Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
    J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
    Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
    JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
    Grauen Larsen H; Yndigegn T; Marinkovic G; Grufman H; Mares R; Nilsson J; Goncalves I; Schiopu A
    Atherosclerosis; 2019 Aug; 287():16-23. PubMed ID: 31181415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.
    Fraty M; Velho G; Gand E; Fumeron F; Ragot S; Sosner P; Mohammedi K; Gellen B; Saulnier PJ; Halimi JM; Montaigne D; Ducrocq G; Rehman M; Marre M; Roussel R; Hadjadj S;
    Diabetologia; 2018 Dec; 61(12):2643-2653. PubMed ID: 30232509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial.
    Filippatos G; Anker SD; Agarwal R; Ruilope LM; Rossing P; Bakris GL; Tasto C; Joseph A; Kolkhof P; Lage A; Pitt B;
    Circulation; 2022 Feb; 145(6):437-447. PubMed ID: 34775784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58.
    Zelniker TA; Morrow DA; Mosenzon O; Goodrich EL; Jarolim P; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding J; Bode C; Lewis BS; Gause-Nilsson I; Langkilde AM; Fredriksson M; Raz I; Sabatine MS; Wiviott SD
    Eur J Heart Fail; 2021 Jun; 23(6):1026-1036. PubMed ID: 33269486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
    Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
    Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
    Berg DD; Wiviott SD; Scirica BM; Zelniker TA; Goodrich EL; Jarolim P; Mosenzon O; Cahn A; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Johanson P; Langkilde AM; Raz I; Braunwald E; Sabatine MS; Morrow DA
    Diabetes Care; 2021 Nov; 44(11):2573-2581. PubMed ID: 34535469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
    Malmstedt J; Kärvestedt L; Swedenborg J; Brismar K
    Cardiovasc Diabetol; 2015 Jul; 14():93. PubMed ID: 26216409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus.
    Cournot M; Burillo E; Saulnier PJ; Planesse C; Gand E; Rehman M; Ragot S; Rondeau P; Catan A; Gonthier MP; Feigerlova E; Meilhac O; Hadjadj S
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.